Georgia Healthcare Group (GHG), which dominates the Georgian healthcare market, saw net profits for 2015 soar 78% year-on-year to GEL 23.6m (€8.5m). Sales also grew by 22.5%, to GEL 242.7m (€87m), reflecting a buoyant and increasingly state driven market. GHG’s CEO, Nikoloz Gamkrelidze, revelled in reaching 30% EBITDA margins ahead of time and now wants a third of the market by sales.



